NovaBridge Biosciences Proceeds from Issuance of Private Placement
NovaBridge Biosciences (NBP) reported Proceeds from Issuance of Private Placement of CNY 2.79 billion for the 12-month period ending 2020-12-31, per its 20-F filed 2023-05-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2023-05-01
- NovaBridge Biosciences proceeds from issuance of private placement for the quarter ending 2020-12-31 was 809.15M CNY.
CNY
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month | Proceeds from Issuance of Private Placement 12 month as first filed |
|---|---|---|---|---|
| 2020-12-31 | 809.15M CNY derived: 20-F 12 month − 6-K 9 month · filed 2023-05-01 | 2.79B CNY 20-F · filed 2023-05-01 | 2.78B CNY 20-F · filed 2021-04-28 | |
| 2020-09-30 | 1.98B CNY 6-K · filed 2021-02-05 |
USD
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|
| 2020-12-31 | $134.73M derived: 20-F 12 month − 6-K 9 month · filed 2021-04-28 | $426.43M 20-F · filed 2021-04-28 | |
| 2020-09-30 | $291.70M 6-K · filed 2021-02-05 |